Lamellolamellar sclerokeratoplasty. Where do we stand today?

被引:9
|
作者
Panda, A [1 ]
机构
[1] AIIAMS, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India
关键词
sclerokeratoplasty; Dessmarre's corneal dissector; King's clamp; glycerin-preserved; Mooren's ulcer; squamous cell carcinoma;
D O I
10.1038/eye.1999.55
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To determine the efficacy of lamellar sclerokeratoplasty for patients with extensive cornea/corneoscleral lesions. Methods One hundred and sixty-six eyes with extensive corneal/corneoscleral lesions of different aetiology who were poor candidates for conventional lamellar keratoplasty/penetrating keratoplasty were selected for lamellar sclerokeratoplasty. Results Corneal clarity of 3+ or more was achieved in 62 eyes by a single procedure. In the remaining 104 eyes graft clarity was < 2+ due to post-surgical complications (n = 56) or remaining recipient deep opacity (n = 48). Conclusions Astigmatism, the bugbear of final visual achievement despite a clear graft, was not a frequent problem following lamellar sclerokeratoplasty. Similarly, a gain in visual acuity to 6/18 or more in 30% of eyes, cosmetic improvement in the majority of cases and prevention of recurrence of the original disease process in susceptible cases all point towards the safety and effectiveness of the procedure. Thus, lamellar sclerokeratoplasty should be considered as a management option for patients with extensive corneal/corneoscleral lesions.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [31] INTRODUCTION: "THE SEXUAL ABERRATIONS"-WHERE DO WE STAND TODAY?
    Moss, Donald
    PSYCHOANALYTIC QUARTERLY, 2014, 83 (02): : 241 - 247
  • [32] Total knee arthroplasty: where do we stand today?
    Aglietti, P
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2005, 13 (03) : 157 - 157
  • [33] CONTROLLED DRINKING TREATMENT - WHERE DO WE STAND TODAY
    HEATHER, N
    ADDICTIVE BEHAVIORS /: PREVENTION AND EARLY INTERVENTION, 1989, : 31 - 50
  • [34] Noise control - Where do we stand today? Foreword
    vonGierke, HEG
    Johnson, DL
    NOISE CONTROL ENGINEERING JOURNAL, 1996, 44 (03) : 107 - 108
  • [35] Pharmaceutical residues in water - where do we stand today?
    Buchberger, W
    NACHRICHTEN AUS DER CHEMIE, 2006, 54 (06) : 673 - 675
  • [36] Experiences with chest trauma: Where do we stand today
    Mohta, M.
    Kumar, P.
    Mohta, A.
    Bhardwaj, R.
    Tyagi, A.
    Sethi, A. K.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2006, 10 (01) : 25 - 28
  • [37] Overall Mortality in Diabetes Mellitus: Where Do We Stand Today?
    Dailey, George
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 : S65 - 74
  • [38] Superior Mesenteric Artery Syndrome: Where Do We Stand Today?
    Tae Hee Lee
    Joon Seong Lee
    Yunju Jo
    Kyung Sik Park
    Jae Hee Cheon
    Yong Sung Kim
    Jae Young Jang
    Young Woo Kang
    Journal of Gastrointestinal Surgery, 2012, 16 : 2203 - 2211
  • [39] Superior Mesenteric Artery Syndrome: Where Do We Stand Today?
    Lee, Tae Hee
    Lee, Joon Seong
    Jo, Yunju
    Park, Kyung Sik
    Cheon, Jae Hee
    Kim, Yong Sung
    Jang, Jae Young
    Kang, Young Woo
    JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (12) : 2203 - 2211
  • [40] The mold conundrum in chronic rhinosinusitis: Where do we stand today?
    Ebbens, Fenna A.
    Fokkens, Wytske J.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2008, 8 (02) : 93 - 101